Journal Article

Antibiotics for community-acquired pneumonia

Matthew Dryden, Kieran Hand and Peter Davey

in Journal of Antimicrobial Chemotherapy

Published on behalf of British Society for Antimicrobial Chemotherapy

Volume 64, issue 6, pages 1123-1125
Published in print December 2009 | ISSN: 0305-7453
Published online October 2009 | e-ISSN: 1460-2091 | DOI:
Antibiotics for community-acquired pneumonia

More Like This

Show all results sharing these subjects:

  • Medical Oncology
  • Critical Care


Show Summary Details


Antibiotic guidelines for community-acquired pneumonia (CAP) often recommend broad-spectrum agents for severe pneumonia. While these may be entirely appropriate in terms of their spectrum of activity and efficacy, there is a risk that such recommendations could result in over-prescribing of broad-spectrum agents with consequent ‘collateral damage’, meaning superinfection by resistant pathogens, or selection of antibiotic resistance. Narrow-spectrum agents are often as effective and result in less collateral damage. National and local antibiotic guidance should promote choices of agents for narrow-spectrum prescribing even for severe CAP where appropriate.

Keywords: CAP; guidelines; prescribing; antibiotic policy; antibiotic stewardship; collateral damage

Journal Article.  1862 words. 

Subjects: Medical Oncology ; Critical Care

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or purchase to access all content.